Published in BMC Fam Pract on February 03, 2012
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
Genetic risk factors for major bleeding in patients treated with warfarin in a community setting. Clin Pharmacol Ther (2014) 0.95
Identifying the risks of anticoagulation in patients with substance abuse. J Gen Intern Med (2013) 0.94
Impact of atrial fibrillation on healthcare utilization in the community: the Atherosclerosis Risk in Communities study. J Am Heart Assoc (2014) 0.85
Impact of stated barriers on proposed warfarin prescription for atrial fibrillation: a survey of Canadian physicians. Thromb J (2014) 0.82
Patient self-management of oral anticoagulation with vitamin K antagonists in everyday practice: efficacy and safety in a nationwide long-term prospective cohort study. PLoS One (2014) 0.80
Comparative effectiveness of dabigatran, rivaroxaban, apixaban, and warfarin in the management of patients with nonvalvular atrial fibrillation. Clin Pharmacol Ther (2013) 0.80
Atrial fibrillation and thromboprophylaxis in heart failure: the need for patient-centered approaches to address adherence. Vasc Health Risk Manag (2013) 0.79
Characterization of patients with atrial fibrillation not treated with oral anticoagulants. Scand J Prim Health Care (2014) 0.78
Patterns of warfarin use in subgroups of patients with atrial fibrillation: a cross-sectional analysis of 430 general practices in the United Kingdom. PLoS One (2013) 0.77
No Decline in the Risk of Stroke Following Incident Atrial Fibrillation Since 2000 in the Community: A Concerning Trend. J Am Heart Assoc (2016) 0.77
Long-term vitamin K antagonists treatment patterns of Non-Valvular Atrial Fibrillation (NVAF): a population-based cohort study. BMC Cardiovasc Disord (2016) 0.75
Trends in the prevalence and management of pre-stroke atrial fibrillation, the South London Stroke Register, 1995-2014. PLoS One (2017) 0.75
Quality of care in patients with atrial fibrillation in primary care: a cross-sectional study comparing clinical and claims data. Ger Med Sci (2016) 0.75
A non-experimental study of oral anticoagulation therapy initiation before and after national patient safety goals. BMJ Open (2014) 0.75
Magnetic resonance imaging of the left atrial appendage post pulmonary vein isolation: Implications for percutaneous left atrial appendage occlusion. J Arrhythm (2014) 0.75
Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med (2009) 39.97
Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke (1991) 22.23
Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med (1994) 10.26
Apixaban in patients with atrial fibrillation. N Engl J Med (2011) 9.97
Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 7.94
Why do patients with atrial fibrillation not receive warfarin? Arch Intern Med (2000) 5.41
Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ (2008) 5.16
Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study. Ann Intern Med (1999) 4.54
Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 4.01
An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. N Engl J Med (1996) 3.86
Translating the results of randomized trials into clinical practice: the challenge of warfarin candidacy among hospitalized elderly patients with atrial fibrillation. Stroke (2006) 3.49
Anticoagulant use for atrial fibrillation in the elderly. J Am Geriatr Soc (2004) 3.13
Geographic variation in health care and the problem of measuring racial disparities. Perspect Biol Med (2005) 2.53
Warfarin use among patients with atrial fibrillation. Stroke (1997) 2.23
Why isn't warfarin prescribed to patients with nonrheumatic atrial fibrillation? J Gen Intern Med (1996) 2.13
Failure to prescribe warfarin to patients with nonrheumatic atrial fibrillation. J Gen Intern Med (1996) 2.10
Physician attitudes concerning warfarin for stroke prevention in atrial fibrillation: results of a survey of long-term care practitioners. J Am Geriatr Soc (1997) 2.09
Newly detected atrial fibrillation and compliance with antithrombotic guidelines. Arch Intern Med (2007) 2.00
Hospitalized patients with atrial fibrillation and a high risk of stroke are not being provided with adequate anticoagulation. J Am Coll Cardiol (2005) 1.97
National trends in antiarrhythmic and antithrombotic medication use in atrial fibrillation. Arch Intern Med (2004) 1.92
Barriers to the use of anticoagulation for nonvalvular atrial fibrillation: a representative survey of Australian family physicians. Stroke (2007) 1.91
Thromboembolism prophylaxis in chronic atrial fibrillation. Practice patterns in community and tertiary-care hospitals. Stroke (1997) 1.89
Quality of care for atrial fibrillation among patients hospitalized for heart failure. J Am Coll Cardiol (2009) 1.81
National patterns of warfarin use in atrial fibrillation. Arch Intern Med (1997) 1.75
Recent national patterns of warfarin use in atrial fibrillation. Circulation (1998) 1.57
Use and effectiveness of warfarin in Medicare beneficiaries with atrial fibrillation. Stroke (2006) 1.53
Racial disparities in awareness and treatment of atrial fibrillation: the REasons for Geographic and Racial Differences in Stroke (REGARDS) study. Stroke (2010) 1.48
Clinical correlation between effective anticoagulants and risk of stroke: are we using evidence-based strategies? South Med J (2004) 1.42
Warfarin discontinuation after starting warfarin for atrial fibrillation. Circ Cardiovasc Qual Outcomes (2010) 1.39
Oral anticoagulation in patients with atrial fibrillation: adherence with guidelines in an elderly cohort. Am J Med (1999) 1.33
Warfarin use following ischemic stroke among Medicare patients with atrial fibrillation. Arch Intern Med (1998) 1.33
Prevalence and quality of warfarin use for patients with atrial fibrillation in the long-term care setting. Arch Intern Med (2001) 1.29
Predictors of anticoagulation prescription in nursing home residents with atrial fibrillation. J Am Med Dir Assoc (2005) 1.29
Warfarin for stroke prevention still underused in atrial fibrillation: patterns of omission. Stroke (2000) 1.15
Doctors' beliefs on the use of antithrombotic therapy in atrial fibrillation: identifying barriers to stroke prevention. Intern Med J (2002) 1.12
Temporal trends in the use of anticoagulants among older adults with atrial fibrillation. Arch Intern Med (1999) 1.12
Predictors of warfarin use in atrial fibrillation patients in the inpatient setting. Am J Cardiovasc Drugs (2010) 1.06
Cost-effectiveness of anticoagulation in nonrheumatic atrial fibrillation in the primary prevention of ischemic stroke. Stroke (1998) 1.01
Predictors of warfarin use among Ohio medicaid patients with new-onset nonvalvular atrial fibrillation. Arch Intern Med (2003) 0.98
Anticoagulation for patients with atrial fibrillation in ambulatory care settings. J Am Board Fam Med (2009) 0.96
Is warfarin really underused in patients with atrial fibrillation? J Gen Intern Med (2001) 0.89
Effect of access to anticoagulation management services on warfarin use in patients with atrial fibrillation. Pharmacotherapy (2005) 0.88
Differential use of warfarin for secondary stroke prevention in patients with various types of atrial fibrillation. Am J Cardiol (2008) 0.85
Differences in quality of care among patients hospitalized with atrial fibrillation as primary or secondary cause for admission. Int J Qual Health Care (2005) 0.85
Racial disparities in the filling of warfarin prescriptions for nonvalvular atrial fibrillation. Am J Med Sci (2007) 0.84
Statins and cancer risk: a meta-analysis. JAMA (2006) 6.28
Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes. JAMA (2010) 4.45
Electrocardiographic and hemodynamic effects of a multicomponent dietary supplement containing ephedra and caffeine: a randomized controlled trial. JAMA (2004) 2.86
Neurothrombectomy devices for the treatment of acute ischemic stroke: state of the evidence. Ann Intern Med (2011) 2.28
Impact of statin dosing intensity on transaminase and creatine kinase. Am J Med (2007) 2.15
Meta-analysis to assess the quality of warfarin control in atrial fibrillation patients in the United States. J Manag Care Pharm (2009) 2.08
Impact of inappropriate antibiotic therapy on mortality in patients with ventilator-associated pneumonia and blood stream infection: a meta-analysis. J Crit Care (2008) 1.91
Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis. Lancet Infect Dis (2007) 1.87
Cost-effectiveness of rivaroxaban compared to warfarin for stroke prevention in atrial fibrillation. Am J Cardiol (2012) 1.79
Prognostic accuracy of clinical prediction rules for early post-pulmonary embolism all-cause mortality: a bivariate meta-analysis. Chest (2015) 1.70
Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors or angiotensin II-receptor blockers for ischemic heart disease. Ann Intern Med (2009) 1.62
Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation (2005) 1.56
The effect of metformin on anthropometrics and insulin resistance in patients receiving atypical antipsychotic agents: a meta-analysis. J Clin Psychiatry (2010) 1.56
Preoperative statins for the prevention of atrial fibrillation after cardiothoracic surgery. J Thorac Cardiovasc Surg (2008) 1.55
Intravenous magnesium sulfate enhances the ability of dofetilide to successfully cardiovert atrial fibrillation or flutter: results of the Dofetilide and Intravenous Magnesium Evaluation. Europace (2009) 1.45
Almonds have a neutral effect on serum lipid profiles: a meta-analysis of randomized trials. J Am Diet Assoc (2009) 1.44
A comparison of two individual amiodarone regimens to placebo in open heart surgery patients. Ann Thorac Surg (2002) 1.43
Association between statin use and mortality in patients with implantable cardioverter-defibrillators and left ventricular systolic dysfunction. Heart Rhythm (2007) 1.42
Differing effect of statins on insulin sensitivity in non-diabetics: a systematic review and meta-analysis. Diabetes Res Clin Pract (2009) 1.42
Effect of nonergot dopamine agonists on symptoms of restless legs syndrome. Ann Fam Med (2008) 1.41
Therapeutic hypothermia is associated with improved neurologic outcome and survival in cardiac arrest survivors of non-shockable rhythms. Resuscitation (2011) 1.41
Fortuitous therapeutic effect of Taser shock for a patient in atrial fibrillation. Ann Emerg Med (2008) 1.39
Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients. Curr Med Res Opin (2014) 1.36
Antihypertensive medication and their impact on cancer incidence: a mixed treatment comparison meta-analysis of randomized controlled trials. J Hypertens (2008) 1.35
The impact of ACE inhibitors or angiotensin II type 1 receptor blockers on the development of new-onset type 2 diabetes. Diabetes Care (2005) 1.22
The effect of statins on the development of new-onset type 2 diabetes: a meta-analysis of randomized controlled trials. Curr Med Res Opin (2008) 1.18
Effect of cinnamon on glucose control and lipid parameters. Diabetes Care (2007) 1.17
Effect of green tea catechins with or without caffeine on anthropometric measures: a systematic review and meta-analysis. Am J Clin Nutr (2009) 1.16
The effects of barley-derived soluble fiber on serum lipids. Ann Fam Med (2009) 1.15
Oral antidiabetic drugs and regression from prediabetes to normoglycemia: a meta-analysis. Ann Pharmacother (2012) 1.11
Effect of pharmacist intervention on glycemic control in diabetes. Diabetes Res Clin Pract (2010) 1.11
Efficacy of statins in combination with interferon therapy in multiple sclerosis: a meta-analysis. Am J Health Syst Pharm (2012) 1.07
Staying healthy. A public mess. Time (2002) 1.06
The impact of coenzyme Q10 on systolic function in patients with chronic heart failure. J Card Fail (2006) 1.02
Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis. Ann Fam Med (2013) 1.02
Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis. Pharmacotherapy (2009) 1.01
Effects of garlic on blood pressure in patients with and without systolic hypertension: a meta-analysis. Ann Pharmacother (2008) 1.00
Cost-effectiveness of apixaban compared with warfarin for stroke prevention in atrial fibrillation. PLoS One (2012) 0.99
Effect of topiramate on weight gain in patients receiving atypical antipsychotic agents. J Clin Psychopharmacol (2013) 0.98
Green tea catechins decrease total and low-density lipoprotein cholesterol: a systematic review and meta-analysis. J Am Diet Assoc (2011) 0.98
The effect of grape seed extract on cardiovascular risk markers: a meta-analysis of randomized controlled trials. J Am Diet Assoc (2011) 0.98
Moxifloxacin and torsade de pointes. Ann Pharmacother (2007) 0.98
Effect of glucomannan on plasma lipid and glucose concentrations, body weight, and blood pressure: systematic review and meta-analysis. Am J Clin Nutr (2008) 0.97
Intravenous plus oral amiodarone, atrial septal pacing, or both strategies to prevent post-cardiothoracic surgery atrial fibrillation: the Atrial Fibrillation Suppression Trial II (AFIST II). Circulation (2003) 0.97
Effect of preoperative angiotensin converting enzyme inhibitor or angiotensin receptor blocker use on the frequency of atrial fibrillation after cardiac surgery: a cohort study from the atrial fibrillation suppression trials II and III. Eur J Cardiothorac Surg (2007) 0.97
Efficacy and safety of innovator versus generic drugs in patients with epilepsy: a systematic review. Pharmacotherapy (2012) 0.96
Electromagnetic Interference (EMI) and arrhythmic events in ICD patients undergoing gastrointestinal procedures. Pacing Clin Electrophysiol (2007) 0.95
Diagnostic accuracy of cardiac positron emission tomography versus single photon emission computed tomography for coronary artery disease: a bivariate meta-analysis. Circ Cardiovasc Imaging (2012) 0.95
Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis. Clin Ther (2008) 0.95
Methods used to conduct and report Bayesian mixed treatment comparisons published in the medical literature: a systematic review. BMJ Open (2013) 0.94
Medication persistence and discontinuation of rivaroxaban versus warfarin among patients with non-valvular atrial fibrillation. Curr Med Res Opin (2014) 0.94
Electrocardiographic and hemodynamic effects of Panax ginseng. Ann Pharmacother (2002) 0.94
Increased clinical failures when treating acute otitis media with macrolides: a meta-analysis. Ann Pharmacother (2010) 0.94
Why we worry about the things we shouldn't...and ignore the things we should. Time (2006) 0.94
Atazanavir: a new protease inhibitor to treat HIV infection. Am J Health Syst Pharm (2004) 0.93
Novel anticoagulants for stroke prevention in atrial fibrillation: a systematic review of cost-effectiveness models. PLoS One (2013) 0.93
Chapter 8: meta-analysis of test performance when there is a "gold standard". J Gen Intern Med (2012) 0.93
Use of N-acetylcysteine to reduce post-cardiothoracic surgery complications: a meta-analysis. Eur J Cardiothorac Surg (2009) 0.91
The association among blood transfusions, white blood cell count, and the frequency of post-cardiothoracic surgery atrial fibrillation: a nested cohort study from the Atrial Fibrillation Suppression Trials I, II, and III. J Cardiothorac Vasc Anesth (2008) 0.90
The Association Between Baseline Left Atrial Volume Index and All-Cause Mortality in Patients with Heart Failure: A Meta-Analysis. Conn Med (2015) 0.89
Dopamine agonists in the treatment of early Parkinson's disease: a meta-analysis. Parkinsonism Relat Disord (2008) 0.89
Evaluating the impact of study-level factors on warfarin control in U.S.-based primary studies: a meta-analysis. Am J Health Syst Pharm (2009) 0.89
Impact of fluid balance on incidence of atrial fibrillation after cardiothoracic surgery. Am J Cardiol (2004) 0.88
Effect of perioperative corticosteroid use on the incidence of postcardiothoracic surgery atrial fibrillation and length of stay. Heart Rhythm (2006) 0.88
Effect of statins on atrial fibrillation after cardiac surgery: a duration- and dose-response meta-analysis. J Thorac Cardiovasc Surg (2010) 0.87
The new drug crisis; addiction by prescription. Time (2010) 0.87
US prevalence of upper gastrointestinal symptoms: a systematic literature review. Am J Manag Care (2011) 0.87
Evaluating the safety implications of aprotinin use: the Retrospective Evaluation of Aprotinin in Cardio Thoracic Surgery (REACTS). J Thorac Cardiovasc Surg (2007) 0.87
Effects of ischemia on repolarization in patients with single and multivessel coronary disease. Pacing Clin Electrophysiol (2003) 0.86
The effect of adding plant sterols or stanols to statin therapy in hypercholesterolemic patients: systematic review and meta-analysis. J Am Coll Nutr (2009) 0.86
Contribution of intangible costs to the economic burden of multiple sclerosis. J Med Econ (2010) 0.86
The gender-paradox among patients with implantable cardioverter-defibrillators: a propensity-matched study. Pacing Clin Electrophysiol (2013) 0.86
Cost-effectiveness of rivaroxaban compared with enoxaparin plus a vitamin K antagonist for the treatment of venous thromboembolism. J Med Econ (2013) 0.85
Indicators of atrial fibrillation risk in cardiac surgery patients on prophylactic amiodarone. Ann Thorac Surg (2004) 0.85
Impact of prophylactic postoperative beta-blockade on post-cardiothoracic surgery length of stay and atrial fibrillation. Ann Pharmacother (2004) 0.85
Safety of amiodarone in the prevention of postoperative atrial fibrillation: a meta-analysis. Am J Health Syst Pharm (2006) 0.85
The impact of suppressing the renin-angiotensin system on atrial fibrillation. J Clin Pharmacol (2006) 0.85
The prognostic impact of shocks for clinical and induced arrhythmias on morbidity and mortality among patients with implantable cardioverter-defibrillators. Heart Rhythm (2010) 0.85
Impact of epicardial anterior fat pad retention on postcardiothoracic surgery atrial fibrillation incidence: the AFIST-III Study. J Am Coll Cardiol (2007) 0.85
The comparative efficacy of plant sterols and stanols on serum lipids: a systematic review and meta-analysis. J Am Diet Assoc (2010) 0.85